Stockreport

Near the top of biotech rankings, AbbVie's Q1 beat makes a case for more upside [Seeking Alpha]

Relay Therapeutics, Inc.  (RLAY) 
PDF full-year earnings outlook on the back of a strong first-quarter revenue beat, and t he results reinforce why the company sits near the very Newsletters for Every Inve [Read more]